Research spanning more than 20 years has led the UPV/EHU's Neurochemistry and Neurodegeneration group under Dr. Rafael Rodríguez-Puertas to discover a promising avenue for the development of new therapies that improve memory in cases of cognitive impairment in neurodegenerative diseases such as Alzheimer's and Parkinson's.
↧